Concord Biotech Announces 1:1 Bonus Share Payout

Concord Biotech Limited has declared its maiden bonus issue, a significant corporate action approved by its board of directors on Wednesday, September 23. The company will issue bonus shares in a 1:1 ratio, meaning eligible shareholders will receive one bonus equity share for every fully paid-up equity share they own.

In conjunction with the bonus issue, the board also approved a substantial increase in the company's authorized share capital. This capital has been raised from ₹11 crore, comprising 11 crore equity shares, to ₹22 crore, divided into 22 crore shares. The company has authorized the creation of an additional 11 crore shares.

The biotech firm, backed by the Jhunjhunwala family, has witnessed robust performance in its stock. As of September 23, the share price closed at ₹1559.20, up by 1.87%. The stock has delivered impressive returns, surging approximately 50.8% over the last six months and around 16.6% year-to-date in 2026. Specific trusts associated with the Jhunjhunwala family hold an 8% stake each in the company.